M-A | Combination therapy with long-acting bronchodilators and risk of adverse cardiovascular events in patients with COPD.

Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis – European Respiratory Journal (link to abstract – $ for full-text)